What’s Her 2 positive breast cancer? What are the characteristics compared to other types?
HeR-2 is also known as “Human skin growth factor receptor-2”, which is an important pre-judgement factor for breast cancer. In fact, there’s a small amount of Her-2 protein on the normal membrane surface of each of us. Within normal cells, Her-2 proteins transmit growth signals from outside the cell to the cell to regulate cell growth and fragmentation. The overexpression of the HeR2 protein on the surface of the HeR2-positive breast cancer cell, which stimulates cancer cells to thrive wildly, increases in intrusiveness and leads to a relatively rapid recurrence and transfer of tumours. Her2-positive breast cancer is a particular type of breast cancer characterized by overexpression or expansion of the HeR2 gene in tumour cells. Compared to other types of breast cancer, Her2 positive breast cancer has some unique characteristics and clinical manifestations. First, herr2-positive breast cancer is more malignant and growing and spreading more rapidly, requiring more active treatment and monitoring. Secondly, this type of breast cancer is more responsive to certain specific drugs, such as those for Her2, which provides more options for treatment. 1. Genetic characteristics: one of the main characteristics of this type of breast cancer is the expansion or overexpression of the HeR2 gene. 2. Incidence rate: Among all breast cancers, Sher2-positive breast cancers account for about 20-30 per cent, but are relatively high in severity and risk of recurrence. 3. Clinical performance: Her2-positive breast cancer patients are often at risk of rapid growth and spread of tumours at an early stage, which can lead to faster progress and higher risk of relapse. 4. Treatment: Her2-positive breast cancer can be treated more effectively with drugs such as tratophorus. These drugs slow the growth and spread of tumours by inhibiting the activity of Her2. 5. Later: Although there is a high degree of nefariousness to her positive breast cancer, the life of the patient can be prolonged through comprehensive treatment and monitoring. At the same time, the application of the HER2 drug has greatly improved the treatment and quality of life of patients. In general, understanding the characteristics of Sher2-positive breast cancer is important for developing effective treatment programmes and monitoring progress. Doctors develop individualized treatment programmes that are tailored to the specific circumstances of the patient in order to achieve optimal treatment.
